Effects of Case Management for Patients With Rheumatoid Arthritis in Taiwan

Rheumatoid Arthritis Clinical Trial

Official title:

The Effectiveness of Case Management for Patients With Rheumatoid Arthritis in Taiwan

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT06341348
• Other study ID #: Dalin Tzuchi Hospital
• Status: Completed
• Phase: N/A
• Start date: January 1, 2016
• Est. completion date: December 31, 2018

Study information

• Verified date: March 2024
• Source: Dalin Tzu Chi General Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Case management (CM) has been recommended as a way of inspiring measurable changes in individual behaviors and improving clinical outcomes for patients with chronic diseases. However, data on its effectiveness for Taiwanese patients with rheumatoid arthritis (RA) are limited. This study aimed to determine the long-term effectiveness of CM that focused on nurses' role among Taiwanese RA patients. A quasi-experimental pre-post test, control-group study with purposive sampling recruited RA patients from a hospital in Taiwan during 2016-2017. CM program was composed of health education sessions and follow-up telephone consultations over a six-month period. A review of medical records and structured questionnaires yielded data about patient demographics and disease characteristics, and included Chinese version of the Arthritis Self-Efficacy Scale and the Taiwanese Depression Questionnaire. A comparison of the long-term effectiveness of the CM program was made using generalized estimating equation. This evidence-based study may be beneficial to characterize the long-term effectiveness of CM for Taiwanese patients with RA, and may be a reference for healthcare providers in facilitating the provision of appropriate interventions to improve the adaptation processes and clinical outcomes for them.

Description:

Nurse-led case management integrates a multi-component intervention comprised of health education and professional advice, as well as referral of clients to other health care team members, discussion of daily life plans, making an appointment for the next clinic, and conducting follow-up sessions by telephone.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 96
• Est. completion date: December 31, 2018
• Est. primary completion date: June 30, 2018
• Accepts healthy volunteers: No
• Gender: All
• Age group: 20 Years to 80 Years

Eligibility

Inclusion Criteria:

• being at least 20 years old at the time of recruitment
• being able to express opinions in either Mandarin or Taiwanese, and
• having a diagnosis of rheumatoid arthritis (RA).

Exclusion Criteria:

• Those having no cognitive impairment and severe complications will be excluded.

Related Conditions & MeSH terms

• Arthritis
• Arthritis, Rheumatoid
• Case Management
• Effectiveness
• Rheumatoid Arthritis

Intervention

Other:
• Case management
Case Management (CM) is multi-component interventions, that comprised the provision of health education and professional advice, referring the client to another health care team, discussing a daily life plan, making reservations, and follow-up by telephone. All interventions were delivered by a nursing case manager who had over 5 years of nursing experience and received more than 20 hours of CM training.

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Dalin Tzu Chi General Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Depressive symptoms	Assessed by Taiwanese Depression Questionnaire	Time 1 (T1): prior to the CM intervention; Time 2 (T2): three days after the CM completion, and Time 3 (T3): three months after CM intervention.
Primary	Self-efficacy level	Assessed by Arthritis Self-Efficacy Scale	Time 1 (T1): prior to the CM intervention; Time 2 (T2): three days after the CM completion, and Time 3 (T3): three months after CM intervention.
Primary	Sexual dysfunctionform-14	Assessed by Changes in Sexual Functioning Questionnaire	Time 1 (T1): prior to the CM intervention; Time 2 (T2): three days after the CM completion, and Time 3 (T3): three months after CM intervention.
Primary	DAS28	Measured by Disease Activity Score of 28	Time 1 (T1): prior to the CM intervention; Time 2 (T2): three days after the CM completion, and Time 3 (T3): three months after CM intervention.